Advertisement
NuAire
NuAire

The Scientist

» clinical trials and developmental biology

Most Recent

image: All In Proportion

All In Proportion

By | March 2, 2013

Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.

0 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

image: Contributors

Contributors

By | March 1, 2013

Meet some of the people featured in the March 2013 issue of The Scientist.

0 Comments

image: Speaking of Science

Speaking of Science

By | March 1, 2013

March 2013's selection of notable quotes

0 Comments

image: Do-It-Yourself Medicine

Do-It-Yourself Medicine

By | March 1, 2013

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

9 Comments

image: Instant Messaging

Instant Messaging

By | March 1, 2013

During development, communication between organs determines their relative final size.

2 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.

0 Comments

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

image: New TB Vaccine Fails Trial

New TB Vaccine Fails Trial

By | February 4, 2013

One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.

1 Comment

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Advertisement